Photocontrolled Binding of Styrylnaphthyridine Ligands to Abasic Site‐containing DNA by Reversible [2+2] Cycloaddition and Cycloreversion
![Photocontrolled Binding of Styrylnaphthyridine Ligands to Abasic Site‐containing DNA by Reversible [2+2] Cycloaddition and Cycloreversion](/_next/image?url=%2F_next%2Fstatic%2Fmedia%2Fplaceholder.d488439a.png&w=3840&q=75)
Five novel styrylnaphthyridine derivatives were synthesized and shown to operate as photoswitchable, selective ligands for abasic site-containing DNA (AP-DNA), which is an important therapeutic and diagnostic target. These compounds associate with AP-DNA with binding constants of 0.5–8.4 × 104 M–1 as shown by photometric and fluorimetric titrations. Specifically, these ligands bind preferentially to AP-DNA relative to regularly paired duplex DNA. As a special feature, the association of these ligands with DNA can be controlled by means of a reversible [2+2] photocycloaddition. Upon irradiation at 420 nm the photodimer is formed, which does not bind to AP-DNA. In turn, the naphthyridine is regained with excitation at 315 nm. Most notably, this photoinduced deactivation and release of the DNA ligand can be performed in situ in the presence of AP-DNA, thus providing a tool for on-demand delivery of a DNA binder. Overall, these results provide a promising starting point for the development of functional AP-DNA ligands whose bioactivity can be modulated by light with local and temporal control.
![Photocontrolled Binding of Styrylnaphthyridine Ligands to Abasic Site‐containing DNA by Reversible [2+2] Cycloaddition and Cycloreversion](/_next/image?url=https%3A%2F%2Fcdn.gdch.de%2Fprod%2Fnadc20264160541_gra_0001_a_b79b5130f5.png&w=256&q=75)
![Photocontrolled Binding of Styrylnaphthyridine Ligands to Abasic Site‐containing DNA by Reversible [2+2] Cycloaddition and Cycloreversion](/_next/image?url=https%3A%2F%2Fcdn.gdch.de%2Fprod%2Flarge_nadc20264160250_fig_0001_a_629b285708.png&w=256&q=75)
![Photocontrolled Binding of Styrylnaphthyridine Ligands to Abasic Site‐containing DNA by Reversible [2+2] Cycloaddition and Cycloreversion](/_next/image?url=https%3A%2F%2Fcdn.gdch.de%2Fprod%2Flarge_nadc20264160375_fig_0001_a_375011f964.png&w=256&q=75)
![Photocontrolled Binding of Styrylnaphthyridine Ligands to Abasic Site‐containing DNA by Reversible [2+2] Cycloaddition and Cycloreversion](/_next/image?url=https%3A%2F%2Fcdn.gdch.de%2Fprod%2Flarge_nadc20264160251_fig_0001_a_90516ca1b6.png&w=256&q=75)
![Photocontrolled Binding of Styrylnaphthyridine Ligands to Abasic Site‐containing DNA by Reversible [2+2] Cycloaddition and Cycloreversion](/_next/image?url=https%3A%2F%2Fcdn.gdch.de%2Fprod%2Flarge_Adobe_Stock_1952534513_DESIGN_LINE_B22_F08418_D6_F4_DEF_9_D9_F9_F440_EF_54865_c0aab04b38.jpeg&w=256&q=75)
